Cannabis is emerging from the shadows of prohibition. Every week, there are advancements in many fields related to cannabis. Smoke Reports will be re-capping the weekly events of the cannabis community and industry, so that you can stay up-to-date on the latest developments.
Medical Journal Finds Cannabinoids Effective for Treatment
It is getting more difficult to deny that cannabis is a medicine. The Journal of the American Medical Association published a clinical review and a systematic review of cannabinoid therapy. Both reviews found that while further study is certainly needed, there is undeniable evidence that cannabis can be used for effective treatment:
“Findings: Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis. Several of these trials had positive results, suggesting that marijuana or cannabinoids may be efficacious for these indications.
Conclusions and Relevance: Medical marijuana is used to treat a host of indications, a few of which have evidence to support treatment with marijuana and many that do not. Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use.”
“Conclusions and Relevance There was moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term AEs.”
JAMA’s publications add further legitimacy to medical cannabis, and soon the federal government will need to re-evaluate the national stance on cannabis. Currently, cannabis is considered under federal law as a Schedule I drug, “with no currently accepted medical use and a high potential for abuse.”
Cannabis Research with Fewer Hurdles
Cannabis research has been sparse, in part because approval for cannabis research involves a lengthy series of reviews and permits. However, the Department of Health and Human Services has decided on Wednesday that the Public Health Service board review was practically identical to the Food and Drug Administration review, and therefore an impediment to the progress of scientific research. While approvals from the FDA, DEA, and the National Institute on Drug Abuse are still required, eliminating the PHS review is one less speed bump for clinical researchers.
Delaware Decriminalizes Cannabis Possession Under One Ounce
Delaware Governor Jack Markell signed a bill (SB 90) last Thursday decriminalizing possession and use of up to an ounce of cannabis. Authorities can still confiscate the drug and write a $100 ticket for personal possession, but the bill is certainly a step in the right direction.
Smoke Reports Expands Services and Education Content
Smoke Reports is incredibly proud to have released the most advanced platform for dispensaries to manage their technology and information. Market data and shared details will improve the overall information available to cannabis patients, and strengthen our community as a whole. To learn more about our dispensary and delivery service accounts, read our blog, or sign up directly on our business page.
Smoke Reports also received a feature in Healing Times Magazine, focusing on the medical efficacy of whole plant cannabis extracts, as opposed to single cannabinoid extractions. This piece was adapted from an older blog post highlighting the results of the studies conducted in Jerusalem. The text of the Healing Times article, “Nature: More Powerful Than Pharmaceuticals” can also be found on our blog.